Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer

NCT02342587 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center